for Journals by Title or ISSN
for Articles by Keywords
Followed Journals
Journal you Follow: 0
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Journals are published.
Already have an account? Sign In to see the journals you follow.
Journal Cover   Medtech Insight
  [0 followers]  Follow
   Full-text available via subscription Subscription journal
   ISSN (Print) 1876-8008
   Published by Informa plc Homepage  [16 journals]
  • Medtech Execs On The Move, December 2015
    • Abstract: Recent executive-level company changes and promotions in the medical device and diagnostics industries.
      PubDate: Tue, 24 Nov 2015 03:00:01 -050
  • PODCAST: Masimo CEO Bets Smart Glasses Are The Future Of Patient
    • Abstract: When Masimo chairman and CEO Joe Kiani saw Atheer's smart glasses and virtual reality platform, he thought the possibilities for patient monitoring were endless. Now the two companies have joined forces and are moving quickly to turn virtual reality into a clinical reality with a prototype interactive display and novel patient monitoring system that they say has the power to transform health care and the market for patient monitoring, which is estimated at more than $2 billion in the US alone according to an upcoming report from Medtech Insight.
      PubDate: Thu, 19 Nov 2015 03:00:00 -050
  • INTERVIEW: Bioabsorbable Stents' No, Drug-Filled Stents Is Way
           Forward, Says Medtronic Cardiac Intervention CMO
    • Abstract: The world’s largest medtech pureplay, Medtronic, believes drug-filled stents (DFSs) will be a major advance in coronary stent technology, which is why it is bypassing bioabsorable technologies like Abbott’s Absorb BVS stent and planning its next steps toward bringing DFSs to market.
      PubDate: Tue, 17 Nov 2015 03:00:00 -050
  • Advanced Wound Care – Untapped Opportunities
    • Abstract: With worldwide revenues projected to reach $6 billion in 2015, mega-deals and innovative game-changing technologies have transformed the advanced wound care market into a robust, high-tech arena in the US. While regulatory and reimbursement challenges persist, opportunities in adjacent spaces and under-penetrated OUS markets represent fertile ground for advanced wound care expansion.
      PubDate: Thu, 12 Nov 2015 03:00:00 -050
  • Another China Player To Watch' Sinocare Targets US Diabetes Market
           With Nipro Diagnostics
    • Abstract: Sinocare Group, a Chinese specialist in biosensor-based blood glucose monitoring devices, is expanding into the US market after agreeing to buy Nipro Corporation’s diabetes business, Nipro Diagnostics. Sinocare gains US manufacturing sites and a ready-made US sales team in the deal, and the move could mark an important turning point in the company's internationalization strategy.
      PubDate: Tue, 10 Nov 2015 07:45:02 -050
  • Baxter’s Amia Automated Home Dialysis System Receives FDA Clearance
    • Abstract: Baxter received FDA 510(k) clearance in October for Amia, a home-based automated peritoneal dialysis system that features voice guidance, touchscreen control and two-way connectivity. With more than 600,000 people in the US living with end-stage renal disease, and 40,000 of these on peritoneal dialysis, the company is working to enhance renal care with patient-centric technologies that provide more individualized and efficient home-based therapy.
      PubDate: Thu, 05 Nov 2015 12:00:01 -050
  • Medical Device Deals Update, November 2015
    • Abstract: Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced September-October 2015.
      PubDate: Mon, 02 Nov 2015 18:00:00 -050
  • TCT 2015: More TAVR Results, Super-Thin Strut Stents, And Percutaneous
           Heart Pumps
    • Abstract: Clinical trials of transcatheter aortic valve technologies once again dominated news coming out of the Transcatheter Cardiovascular Therapeutics conference, held this year in San Francisco, October 10–15. But the meeting also featured new coronary stent technologies and new information on percutaneous heart pumps to support patients during difficult interventions.
      PubDate: Thu, 29 Oct 2015 00:00:22 -040
  • Absorbing Debate: Boston Sci, Abbott Differ On Whether The Future Of
           Stents Is To Disappear
    • Abstract: Competing visions of the future of percutaneous coronary interventions were on display at TCT year, with Boston Scientific pushing its Synergy bioabsorbable polymer-coated, drug-eluting metal stent platform as the better long-term option to fully-resorbable scaffolds of the type Abbott is first out of the gate with.
      PubDate: Thu, 29 Oct 2015 00:00:06 -040
  • Orthonika: Total Meniscus Replacement
    • Abstract: Orthonika Ltd., a spin-out from Imperial College London, is developing TMR, which it describes as the first total knee meniscus replacement. The start-up's implant is based on a proprietary polymer substrate that mimics the structure and function of the healthy meniscus, and the attachment mechanisms to the bone.
      PubDate: Thu, 29 Oct 2015 00:00:01 -040
  • AdvaMed 2015: Innovation Spotlight On Diabetes, Heart Failure Start-Ups
    • Abstract: Medtech start-ups continue to bring fresh ideas and new approaches to a market that is continually looking for better and cheaper treatment options. The device industry’s major trade association recently featured dozens of start-ups at its annual conference, and companies offering new solutions to battle chronic diseases were among the highlights.
      PubDate: Wed, 28 Oct 2015 08:00:00 -040
  • Oncimmune Set For Bigger US Push Of Early-Stage Lung Cancer Test
    • Abstract: Oncimmune Ltd. is seeking new distribution partners in the US as it expands commercialization of its a one-of-a-kind immunoassay for early-stage lung cancer that can detect circulating antibodies in the blood of patients with lung cancer up to four years before standard imaging tests. Positive interim data from a UK randomized clinical trial is expected to help fuel uptake of the test.
      PubDate: Tue, 27 Oct 2015 10:45:01 -040
  • Who's Next' Emerging LAA Closure Devices
    • Abstract: As first-to-market in the US with a transcatheter left atrial appendage closure device, Boston Scientific has blazed a regulatory and reimbursement trail for other companies in this space and opened up a potentially billion-dollar-plus market. In this second part of our two-part series on LAAC devices, Medtech Insight reports on other companies with current and emerging LAAC devices and looks at how close they are to bringing their technology to the US market.
      PubDate: Mon, 26 Oct 2015 13:00:00 -040
  • Device/Pharma Companies Leverage Digital Tools To Monitor Medication
    • Abstract: Digital health tools, pharmaceuticals and medical devices are converging in new wireless technologies designed to remotely monitor patient medication-taking behavior and to measure physiological responses to some drugs. Companies say these connected devices and services will help improve medication adherence and patient outcomes, and will save the health care system billions of dollars by preventing unnecessary doctor's visits and hospital admissions.
      PubDate: Wed, 21 Oct 2015 18:00:01 -040
  • Noninvasix: Optoacoustic Fetal Monitoring
    • Abstract: Noninvasix Inc. uses optoacoustics to noninvasively measure oxygenation of the brain, without any influencing variables, to determine fetal distress. The company says its method eliminates some of the problems associated with pulse oximetry or near-infrared spectroscopy, such as degradation of accuracy with low blood pressure.
      PubDate: Wed, 21 Oct 2015 08:00:25 -040
  • Global Molecular Diagnostics Market To Reach $7.3B By 2019
    • Abstract: The global molecular diagnostics market will grow by $2.4 billion over the next five years according to a global market report from Medtech Insight. Major factors contributing to the healthy growth of this market include advances in technology, as well as the growing understanding of the human genome, pharmacogenomics and the relationship between genes and disease/infection.
      PubDate: Mon, 19 Oct 2015 18:00:02 -040
  • Medtronic’s MRI-Compatible ICD System Receives FDA Approval
    • Abstract: The first implantable cardioverter defibrillator system for use with an MRI scan has been approved by the FDA: the Evera MRI SureScan ICD System from Medtronic. The company hopes the system, which will allow clinicians to conduct important imaging studies of all anatomical locations, will give Medtronic a competitive edge over other ICDs, and will lead to market share gains in the US.
      PubDate: Fri, 16 Oct 2015 08:00:00 -040
  • Medtech Execs On The Move, October 2015
    • Abstract: Recent executive-level company changes and promotions in the medical device and diagnostics industries.
      PubDate: Thu, 15 Oct 2015 08:00:01 -040
  • Medical Device Deals Update, October 2015
    • Abstract: Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced August-September 2015.
      PubDate: Mon, 05 Oct 2015 17:00:01 -040
  • LAA Closure Devices: Cardiology Societies Weigh In
    • Abstract: In June 2015, three cardiology societies issued a clinical overview on implantation of left atrial appendage closure devices that is the first in a series of documents highlighting the critical issues that need to be addressed in order to integrate these new technologies into clinical practice.
      PubDate: Tue, 29 Sep 2015 00:00:24 -040
  • LAA Closure Devices At The Tipping Point
    • Abstract: Since the FDA approval of Boston Scientific Corp.'s WATCHMAN device in March, the US market for left atrial appendage closure devices has reached a tipping point. With first-to-market advantage in the US, and a four- to five-year lead on the competition in bringing a LAAC device to the US market, BSX is well positioned to gain a strong foothold in this potentially billion dollar plus market; however, several factors will dictate market adoption of these devices in the US, including reimbursement, clinical efficacy, cost and ease of use.
      PubDate: Tue, 29 Sep 2015 00:00:15 -040
  • Urgent Changes Needed To Spur Indian Device Sector
    • Abstract: India has promised to change import duties seen as discouraging the local manufacture of medical devices, as a report forecasts that industry sales could increase nearly eight-fold to $50bn in a decade with the right tariffs, regulatory structure, quality image and manufacturing skills.
      PubDate: Tue, 29 Sep 2015 00:00:11 -040
  • Wright Sees Potential $1B+ Market Opportunity With Newly-Approved
    • Abstract: The Augment biologic-based device was approved for use in ankle and hindfoot fusions after overcoming multiple regulatory challenges, opening up a $300 million US market opportunity. It's the first indication for a product platform that Wright hopes to extend to use in soft-tissue procedures such as rotator cuff or tennis elbow repair, which represent a $1 billion-plus opportunity.
      PubDate: Tue, 29 Sep 2015 00:00:03 -040
  • Genetic Biomarkers Offer New Hope In Identifying Prostate Cancer
    • Abstract: Although physicians still struggle with the best ways to treat patients suspected of having prostate cancer, a new group of genetic-based tests could provide new tools that will help improve diagnostic accuracy. These new biomarkers offer hope in reducing the number of patients who receive unnecessary treatment for cancers that are not actually present in their bodies and for those cancers not aggressive enough to cause harm.
      PubDate: Thu, 24 Sep 2015 16:00:00 -040
  • ESC 2015: ‘Shocking’ Outcomes Of Sleep Apnea-Heart Failure
           Trial Spell Gloom For ResMed
    • Abstract: Results from the SERVE-HF trial, presented at the recent European Society of Cardiology meeting and published in the NEJM, showed systolic heart failure patients with central sleep apnea treated with adaptive servo-ventilation actually had worse mortality outcomes than the control group. These results "shocked " both the respiratory and cardiology community and spell gloom for ResMed's sleep apnea therapy.
      PubDate: Mon, 21 Sep 2015 16:00:01 -040
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2015